凝类类化合物在抑制性受体上的分子药理学
Ana M Marileo1,2, César O Lara1,2, Anggelo Sazo1,2
1Department of Physiology, Faculty of Biological Sciences, Universidad de Concepcion, Concepción 4070386, Chile.
International journal of molecular sciences
|March 28, 2024
概括
凝类类化合物调节中枢神经系统的受体,如甘氨酸和GABA-A受体. 这项研究确定了关键的分子相互作用,澄清了它们的复杂效应和毒性.
科学领域:
- 神经药理学神经药理学
- 分子生物学分子生物学
- 药用化学 医学化学
背景情况:
- Gelsemium类化合物是来自Gelsemium植物的生物活性化合物,具有中枢神经系统效应,但分子标定义不佳.
- 这些类化合物在哺乳动物中表现出毒性,需要更深入地了解它们与神经元点的相互作用.
- 已知Gelsemine可以调节甘氨酸受体 (GlyRs) 和GABA-A受体 (GABA-A Rs),这是中枢神经系统中关键的联结离子通道.
研究的目的:
- 阐明主要的Gelsemium内醇化物 (koumine,gelsemine,gelsevirine,humantenmine) 与GlyRs和GABA-A Rs的分子标和相互作用.
- 定义药理学特征,并确定控制这些相互作用的分子和物理化学决定因素.
- 扩大有关这些天然化合物如何与中枢神经系统蛋白标相互作用的知识.
主要方法:
- 电生理学记录被用来评估类化合物对离子通道的功能影响.
- 生物信息学方法,包括药模拟,用于分析分子相互作用.
- 研究涉及野生类型,嵌合体和突变的GlyRs,以确定化物结合和调节的关键区域.
主要成果:
- 库和尔塞维林抑制了GlyRs (α1,α2,α3亚单元),而人胺没有显示任何活性.
- 库明抑制了GABA-A Rs,而人胺却没有效果.
- 细胞外域和GlyRs的ortosteric站点残留对类化合物效应至关重要;药模拟揭示了关键的物理化学特征.
结论:
- 这项研究为Gelsemium类化合物与GlyRs和GABA-A Rs的相互作用的分子决定因素提供了新的见解.
- 这些发现澄清了koumine,gelsemine,gelsevirine和humantenmine在抑制性中枢神经系统受体上的功能作用.
- 了解这些相互作用对于评估Gelsemium类化合物的治疗潜力和毒性至关重要.
更多相关视频
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
G-Protein Gated Ion Channels
4.6K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.6K
G-protein Coupled Receptors
118.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.6K
Drugs Acting on Autonomic Ganglia: Blockers
1.0K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.0K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
558
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
558
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K


